IP Verse

Mesenchymal Stem Cells And Uses Therefor - EP2298864

The patent EP2298864 was granted to Mesoblast on Oct 11, 2017. The application was originally filed on Mar 15, 2005 under application number EP10011226A. The patent is currently recorded with a legal status of "Revoked".

EP2298864

MESOBLAST
Application Number
EP10011226A
Filing Date
Mar 15, 2005
Status
Revoked
Feb 22, 2022
Grant Date
Oct 11, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

FRIEDRICHJul 11, 2018DORRIESADMISSIBLE
FRIEDRICHJul 11, 2018DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMANADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS5486359
DESCRIPTIONUS6355239
OPPOSITIONWO2004007697
SEARCHWO0006701
SEARCHWO02064182
SEARCHWO03078567
SEARCHWO2004006942
SEARCHWO2004007697
SEARCHWO2005001076
SEARCHWO2005013885

Non-Patent Literature (NPL) Citations (63) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BALLAS ET AL., J. CELL. BIOCHEM. SUPPL., (2002), vol. 38, page 20-
DESCRIPTION- BARTHOLOMEW ET AL., EXP. HEMATOL., (2002), vol. 30, page 42-
DESCRIPTION- CHOPP ET AL., NEUROREPORT, (2000), vol. 11, page 3001-
DESCRIPTION- DEKOK ET AL., CLIN. ORAL IMPLANTS RES., (2003), vol. 14, page 481-
DESCRIPTION- DENICOLA ET AL., BLOOD, (2002), vol. 99, page 3838-
DESCRIPTION- DEVINE ET AL., CANCER J., (2001), vol. 7, page 576-
DESCRIPTION- DINICOLA ET AL., BLOOD, (2002), vol. 99, page 3838-
DESCRIPTION- DZIONEK, J. IMMUNOL., (2000), vol. 165, page 6037-
DESCRIPTION- EAVES ET AL., ANN. N.Y. ACAD. SCI, (2001), vol. 938, page 63-
DESCRIPTION- FAKUDA, ARTIF. ORGANS., (2001), vol. 25, page 187-
DESCRIPTION- HARRIS ET AL., TRENDS IMMUNOL., (2002), vol. 23, page 144-
DESCRIPTION- HAYNESWORTH ET AL., BONE, (1992), vol. 13, page 69-
DESCRIPTION- HAYNESWORTH ET AL., J. CELL. PHYSIOL., (1996), vol. 166, page 585-
DESCRIPTION- HOROWITZ ET AL., PROC. NAT. ACAD. SCI., (2002), vol. 99, page 8932-
DESCRIPTION- HORWITZ ET AL., BLOOD, (2001), vol. 97, page 1227-
DESCRIPTION- KINGSLEY ET AL., J. IMMUNOL., (2002), vol. 168, page 1080-
DESCRIPTION- KOC ET AL., J. CLIN. ONCOL., (2000), vol. 18, page 307-
DESCRIPTION- LE BLANC ET AL., EXP. HEMATOL., (2003), vol. 31, page 890-
DESCRIPTION- LEBLANC ET AL., EXP. HEMATOL., (2003), vol. 31, page 890-
DESCRIPTION- LEBLANC ET AL., SCAND. J. IMMUNOL., (2003), vol. 57, page 11-
DESCRIPTION- LEBLANC ET AL., SCAND J. LMMUNOL., (2003), vol. 57, page 11-
DESCRIPTION- MACKENZIE ET AL., BLOOD CELLS MOL. DIS., (2002), vol. 27-
DESCRIPTION- MAJUMDAR ET AL., HEMATOTHER. STEM CELL RES., (2000), vol. 9, page 841-
DESCRIPTION- MAJUMDAR ET AL., J. BIOMED. SCI., (2003), vol. 10, page 228-
DESCRIPTION- NOEL ET AL., CURR. OPIN. LNVESTIQ. DRUOS., (2002), vol. 3, page 1000-
DESCRIPTION- PEREIRA ET AL., PROC. NAT. ACAD. SCI., (1998), vol. 95, page 1142-
DESCRIPTION- PITTENGER ET AL., SCIENCE, (1999), vol. 284, page 143-
DESCRIPTION- POTIAN ET AL., J. IMMUNOL., (2003), vol. 171, page 3426-
DESCRIPTION- PROCKOP, SCIENCE, (1997), vol. 276, page 71-
DESCRIPTION- SANCHEZ-RAMOS ET AL., EXP. NEUROL., (2001), vol. 171, page 109-
DESCRIPTION- SCHWARTZ ET AL., HUM. GENE THER., (1999), vol. 10, page 2539-
DESCRIPTION- SHAKE ET AL., ANN. THORAC. SURQ., (2002), vol. 73, page 1919-
DESCRIPTION- TOMA ET AL., CIRCULATION, (2002), vol. 105, page 93-
DESCRIPTION- TOMITA ET AL., CIRCULATION, (1999), vol. 100, page 247-
DESCRIPTION- TSE ET AL., TRANSPLANTATION, (2003), vol. 75, page 389-
DESCRIPTION- VASSILIOU ET AL., CELL. IMMUNOL., (2003), vol. 223, page 120-
DESCRIPTION- WAGERS ET AL., GENE THERAPY, (2002), vol. 9, page 606-
DESCRIPTION- WAKITANI ET AL., MUSCLE NERVE, (1995), vol. 18, page 1417-
DESCRIPTION- WOODBURY ET AL., J. NEUROSCI. RES., (2002), vol. 69, page 908-
DESCRIPTION- WU ET AL., J. NEUROSCI. RES., (2003), vol. 72, page 393-
DESCRIPTION- WU ET AL., TRANSPLANTATION, (2003), vol. 75, page 679-
OPPOSITION- AI, G. et al., Natl. Med. J. China, (20020000), vol. 82, no. 23-
OPPOSITION- JORGENSEN, C. et al., "Mesenchymal stem cells and rheumatoid arthritis", Joint Bone Spine, (20030000), vol. 70, pages 483 - 485, XP009145230-
OPPOSITION- LUNDBERG, J. E. et al., "Comparison of IL-10 levels in chronic venous insufficiency ulcers and autologous donor tissue.", Arch. Dermatol. Res., (19980000), vol. 290, pages 669 - 673, XP055504494-
OPPOSITION- Original copy of D11-
OPPOSITION- RASMUSSON, I. et al., "Human mesenchymal stem cells increase interleukin-2 and soluble IL-2 receptor in mixed lymphocyte cultures", (20040000), vol. 33, page S87-
OPPOSITION- Stedman's Medical Dictionary, (20000000), page 1865, 1990-
OPPOSITION- WANG, J. F. et al., "The pig as a model for excisional skin wound healing: characterization of the molecular and cellular biology, and bacteriology of the healing process.", Comparative Med., (20010800), vol. 51, no. 4, pages 341 - 348, XP009033713-
OPPOSITION- BADIAVAS, E. V. et al., "Treatment of Chronic Wounds With Bone Marrow-Derived Cells", Arch. Dermatol., (20030000), vol. 139, no. 4, pages 510 - 516, XP055504122
OPPOSITION- BARRY, F. P., "Biology and clinical applications of mesenchymal stem cells", Birth defects Res., (20030000), vol. 69, pages 250 - 256, XP002976497
OPPOSITION- DEANS, R. J. et al., "Mesenchymal stem cells: Biology and potential clinical uses", Exp. Hematol., (20000000), vol. 28, no. 8, pages 875 - 884, XP002201188
OPPOSITION- HESHMATI, F., "Mechanisms of action of extracorporeal photochemotherapy", Transfusion and Apheresis Science, (20030000), vol. 29, pages 61 - 70, XP002977587
OPPOSITION- LORIMORE, S. A. et al., "Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects?", Oncogene, (20010000), vol. 20, pages 7085 - 7095, XP055504491
OPPOSITION- BACIGALUPO, A. et al., "Management of acute graft versus host disease (GvHD)", Hematol. J., (20040000), vol. 5, no. 3, pages 189 - 196, XP055496392
OPPOSITION- ORTIZ, L. A. et al., "Mesenchymal stem cell engraftment in lung is enhanced bleomycin exposure and ameliorates its fibrotic effects", Proceedings Natl. Acad. Sci. USA, (20030000), vol. 100, no. 14, pages 8407 - 8411, XP003015827
OPPOSITION- LE BLANC, K., "Immunomodulatory effects of fetal and adult mesenchymal stem cells", Cytotherapy, (20030000), vol. 5, no. 6, pages 485 - 489, XP008075543
OPPOSITION- SERHAN, C. N. et al., "Resolution of inflammation: state of the art, definitions and terms", Europe PMC Funders Group Author Manuscript, (20070000), vol. 21, no. 2, pages 1 - 12, XP055504485
OPPOSITION- PHILLIPS, S. J., "Physiology of Wound Healing and Surgical Wound Care", ASAIO J., (20000000), pages S2 - S5, XP055108390
OPPOSITION- WERNER, S. et al., "Regulation of wound healing by growth factors and cytokines", Physiol Rev., (20030000), vol. 83, no. 3, pages 835 - 870, XP002672025
OPPOSITION- GILLITZER, R et al., "Chemokines in cutaneous wound healing", J. Leukocyte Biol., (20010000), vol. 69, pages 513 - 521, XP055504278
OPPOSITION- ANDREW, J. G. et al., "Inflammatory cells in normal human fracture healing", Acta Orth. Scand., (19940000), vol. 65, no. 4, pages 462 - 466, XP055504497
SEARCH- CARMELIET P ET AL, "THE EMERGING ROLE OF THE BONE MARROW-DERIVED STEM CELLS IN (THERAPEUTIC) ANGIOGENESIS", THROMBOSIS AND HAEMOSTASIS, SCHATTAUER GMBH, DE; US, (20010701), vol. 86, no. 1, ISSN 0340-6245, pages 289 - 297, XP009014929 [X] 6-12 * whole document esp. abstract and page 294 *-
SEARCH- TANG Y L ET AL, "Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium", REGULATORY PEPTIDES, ELSEVIER SCIENCE BV, NL, (20040115), vol. 117, no. 1, doi:10.1016/J.REGPEP.2003.09.005, ISSN 0167-0115, pages 3 - 10, XP002333008 [X] 6-12 * whole document esp. abstract, pages 4,8,9 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents